Search

This study explores flame structures and combustion dynamics in high-pressure n-dodecane fuel sprays, focusing on the formation and consumption of formaldehyde (CH2O) during autoignition and the development of poly-aromatic hydrocarbons (PAH) as soot precursors. These processes are crucial for optimizing combustion efficiency and reducing emissions. However, traditional approaches, which rely on single-shot measurements or ensemble-averaged visualizations, often overlook critical early-stage processes during low-temperature ignition. To overcome these challenges, we employed an innovative high-speed planar laser-induced fluorescence (PLIF) technique at 50 kHz using a pulse-burst Nd:YAG laser system with an excitation wavelength of 355 nm. This approach, applied for the first time to Engine Combustion Network (ECN) Spray D flames, provides unprecedented insights into the combustion processes at varying ambient temperatures and oxygen concentrations. Additionally, simultaneous high-speed schlieren imaging at 100 kHz was used to visualize spray penetration, first-stage ignition, and thermal expansion zones. Our findings reveal that, similar to Spray A flames, CH2O forms in cold, fuel-rich zones well upstream of the combustion zone. However, in Spray D flames, the schlieren signal softening observed in the jet's head does not lead to complete disappearance, and the CH2O signal is absent from the full head of the spray. During the second-stage ignition, CH2O consumption accelerates due to high-temperature reactions, leading to a significant reduction in its signal. Unlike the mushroom-shaped structure seen in Spray A flames, Spray D flames exhibit a quasi-steady PAH phase structure, with lean peripheral mixtures insufficient for soot precursor formation. Notably, reducing ambient oxygen concentration to 13 % while maintaining or increasing temperature prolongs the presence of CH2O, highlighting its influence on ignition dynamics and oxidation processes in dodecane spray flames. This study provides new insights into the combustion mechanisms of high-pressure sprays and offers valuable data for developing next-generation combustion technologies, including models, aimed at improving efficiency and reducing emissions.

In the EU funded SmartCHP project, biomass derived fast-pyrolysis bio-oil (FPBO) is used to fuel modified stationary diesel engines for combined heat and power applications. In this study, the spray combustion characteristics of fast-pyrolysis bio-oil and FPBO/ethanol blends are experimentally investigated in a combustion research unit. Due to the special physicochemical properties of fast-pyrolysis bio-oil, major modifications are made to the combustion research unit to facilitate testing this fuel, including the installation of a high-temperature chamber and a heavy-fuel oil injection system. Experimental tests are carried out at a chamber wall temperature of 750 °C and an ambient pressure of 50 bar. The pressure-based heat release analysis is used to evaluate fuel ignition and combustion characteristics, while a high-speed imaging technique is adopted to visualize natural luminosity of spray flames through a borescope.Results show that fast-pyrolysis bio-oil has lower sooting tendency than diesel, and it significantly alleviates the fuel dribble phenomenon. At injection pressure of 300 bar, the poor atomization of fast-pyrolysis bio-oil leads to rather grainy-looking spray flame images, and nozzle orifices becoming clogged within couple of injections. The increase of injection pressure to 900 bar results in an obvious improvement of the atomization quality and nozzle durability for fast-pyrolysis bio-oil. Adding ethanol into fast-pyrolysis bio-oil could improve fuel atomization and further reduce the natural luminosity. The ignition delay of fast-pyrolysis bio-oil is slightly retarded by 10% ethanol addition, while it is advanced by 30% ethanol addition.

In this study, the ignition and combustion characteristics of fast pyrolysis bio-oil (FPBO) are investigated in a combustion research unit (CRU), which mainly consists of a constant-volume combustion chamber. To fuel the CRU with FPBO, n-butanol and 2-ethylhexyl nitrate (EHN) are used to improve the atomization and ignition properties of the fuel blends, respectively. In the first part of this study, an appropriate proportion of EHN additive into n-butanol is determined based on the balance between the ignition improvement and the amount of EHN addition. Then, the effects of FPBO content (up to 30%) in FPBO/n-butanol blends with the same EHN addition are investigated. The effects of chamber wall temperature on the combustion are also studied. Finally, the different definitions of indicators are determined from the chamber pressure traces to quantitatively depict fuel ignition and combustion characteristics including ignition delay, combustion phasing, end of combustion and burn duration. Experimental results show that a distinct two-stage ignition process can be observed for all cases. For n-butanol with added EHN, the increase of EHN proportion could effectively advance both the low- and high-temperature reaction phases. However, this gain is obviously reduced when the percentage of EHN becomes higher than 8%. For FPBO/n-butanol blends with an addition of EHN, higher FPBO proportions have little effect on the low-temperature reaction phase, while they delay the high-temperature reaction phase. Chamber wall temperature have a significant influence on the ignition and combustion processes of the tested FPBO/n-butanol blends. With these blends, negative temperature coefficient behavior was observed in a chamber wall temperature range of 535–565°C.

Importance: Patient-reported outcome (PRO) measures address the need for patient-centered data and are now used in diverse clinical, research, and policy pursuits. They are important in conditions causing upper airway-related dyspnea in which the patient's reported experience and physiological data can be discrepant., Objectives: To perform a systematic review of the literature on upper airway dyspnea-related PRO measures and to rigorously evaluate each measure's developmental properties, validation, and applicability., Evidence Review: This study strictly adhered to Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines. MEDLINE via the PubMed interface, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), and the Health and Psychosocial Instruments (HaPI) database were searched using relevant vocabulary terms and key terms related to PRO measures and upper airway-related dyspnea. Three investigators performed abstract review, and 2 investigators independently performed full-text review by applying an established checklist to evaluate the conceptual model, content validity, reliability, construct validity, scoring and interpretability, and respondent burden and presentation of each identified instrument. The initial literature search was conducted in November 2014 and was updated in April 2016., Findings: Of 1269 studies reviewed, 3 upper airway-related dyspnea PRO measures met criteria for inclusion. One PRO measure was designed de novo to assess upper airway-related dyspnea symptoms and monitor treatment outcomes, while 2 were adapted from established instruments designed for lower airway disease. Measurement properties and psychometric characteristics differed, and none met all checklist criteria. Two met a criterion in each of 7 domains evaluated. Two demonstrated test-retest and internal consistency reliability, and 2 showed that their scores were responsive to change. Thematic deficiencies in current upper airway-related dyspnea PRO measures are lack of patient involvement in item development (content validity), plan for interpretation, and literacy level assessments., Conclusions and Relevance: PRO measures are critical in the assessment of patients with upper airway-related dyspnea. Three instruments with disparate developmental rigor have been designed or adapted to assess this construct. Care must be taken to understand the measurement characteristics and contextual relevance before applying these PRO measures for clinical, research, or quality initiatives.

Background: Modern flexible multiple daily injection (MDI) therapy requires people with diabetes to manage complex mathematical calculations to determine insulin doses on a day to day basis. Automated bolus calculators assist with these calculations, add additional functionality to protect against hypoglycaemia and enhance the record keeping process, however uptake and use depends on the devices meeting the needs of the user. We aimed to obtain user feedback on the usability of a mobile phone bolus calculator application in adults with T1DM to inform future development of mobile phone diabetes support applications., Methods: Adults with T1DM who had previously received education in flexible MDI therapy were invited to participate. Eligible respondents attended app education and one month later participated in a focus group to provide feedback on the features of the app in relation to usability for patient-based flexible MDI and future app development., Results: Seven adults participated in the app training and follow up interview. App features that support dose adjustment to reduce hypoglycaemia risk and features that enable greater efficiency in dose calculation, record keeping and report generation were highly valued., Conclusions: Adults who are self managing flexible MDI found the Rapidcalc mobile phone app to be a useful self-management tool and additional features to further improve usability, such as connectivity with BG meter and food databases, shortcut options to economise data entry and web based storage of data, were identified. Further work is needed to ascertain specific features and benefit for those with lower health literacy.

Background: The purpose of this study was to advance a checklist of evaluative criteria designed to assess patient-reported outcome (PRO) measures' developmental measurement properties and applicability, which can be used by systematic reviewers, researchers, and clinicians with a varied range of expertise in psychometric measure development methodology., Methods: A directed literature search was performed to identify original studies, textbooks, consensus guidelines, and published reports that propose criteria for assessing the quality of PRO measures. Recommendations from these sources were iteratively distilled into a checklist of key attributes. Preliminary items underwent evaluation through 24 cognitive interviews with clinicians and quantitative researchers. Six measurement theory methodological novices independently applied the final checklist to assess six PRO measures encompassing a variety of methods, applications, and clinical constructs. Agreement between novice and expert scores was assessed., Results: The distillation process yielded an 18-item checklist with six domains: (1) conceptual model, (2) content validity, (3) reliability, (4) construct validity, (5) scoring and interpretation, and (6) respondent burden and presentation. With minimal instruction, good agreement in checklist item ratings was achieved between quantitative researchers with expertise in measurement theory and less experienced clinicians (mean kappa 0.70; range 0.66-0.87)., Conclusions: We present a simplified checklist that can help guide systematic reviewers, researchers, and clinicians with varied measurement theory expertise to evaluate the strengths and weakness of candidate PRO measures' developmental properties and the appropriateness for specific applications.

We begin by defining the concept of a 'CareMap', before briefly examining the context in which CareMaps emerged, as well as both their potential applications and the benefits arising from their implementation in health care services. We identify and discuss the history of, and critical aspects involved in, the development of the Antenatal Ward Care Delivery Map for the Mater Mothers' Hospital, Brisbane. We will address the multiple applications of, and specific benefits arising from, the formulation and implementation of the Antenatal Ward Care Delivery Map. Additionally, the relationship between the Care Delivery Map and other projects aimed at enhancing and maintaining high quality service delivery for patients across the continuum of care, will be explored. We examine the benefits of utilising the Care Delivery Map in professional education for clinical staff, as well as for health care consumers and their families. In conclusion, future projects enabled through the development of the Care Delivery Map are identified, as well as areas requiring further research.